|
Date Submitted:
12/12/07
Hits: 15 Rating:  0/5 based on 0 votes
Direct-to-Consumer Drug Ads Booming Despite Criticisms
Description:
Drug company spending on direct-to-consumer advertising continues to skyrocket, even as criticisms against it have soared.
Calling for a moratorium, rather than just restrictions, on such advertising might be in order, say the authors of a study in the Aug. 16 issue of the New England Journal of Medicine. "Direct-to-consumer advertising spending is increasing in terms of its share of total marketing budget, but it's still a smaller share relative to promotion aimed at influencing prescribers," said study author Julie M. Donohue, an assistant professor of health policy and management at the University of Pittsburgh Graduate School of Public Health. The U.S. Food and Drug Administration started allowing direct-to-consumer advertising of prescription drugs on television 10 years ago. Since that time, spots of Dorothy Hamill and Sally Field peddling Vioxx and Boniva, respectively, cartoon characters illustrating the effects of the antidepr Read the Complete Article Similar content: Hepatitis B Drug Triggers HIV Drug Resistance, in Hepatitis New Hepatitis B Drug Better Than Others, in Hepatitis What causes JME to be drug-resistant?, in Epilepsy No to Over-The-Counter Cholesterol Drug, in Heart Disease Epilepsy Drug Linked to Low IQ, in Epilepsy |
